On March 14, 2022, Raymond Pratt notified Rockwell Medical, Inc. of his decision to resign as the Company's Chief Development Officer, effective as of March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.895 USD | +0.26% | +5.87% | +0.26% |
05-30 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
05-14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.26% | 57.3M | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-3.92% | 159B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Raymond Pratt Resigns from Rockwell Medical, Inc. as Chief Development Officer, Effective March 25, 2022